Key facts
- Wall Street banks have issued initial research notes on SpaceX following its IPO.
- Most analysts recommend buying the stock with price targets above $200.
- SpaceX stock is currently trading around $152 per share.
- Key growth areas cited include space transportation, Starlink, and AI innovations.
- Raymond James has a highly optimistic outlook, forecasting $800 per share.
- MoffettNathanson holds a neutral rating with a $131 price target due to uncertainties.
Wall Street banks have issued their first research notes on SpaceX following its initial public offering, with most recommending investors buy the stock and forecasting prices above $200 in the next 12 to 18 months. However, the stock is currently trading around $152 per share, just above its IPO day opening price. Investors appear cautious, focusing on factors such as regulatory issues, technological development, and demand uncertainties, despite analysts' enthusiasm for SpaceX's potential leadership in space transportation and infrastructure.
J.P. Morgan analysts described SpaceX's ambitions as "bigger than any company's we've ever seen." The company's reusable rockets and Starlink satellite technology are key revenue drivers, with AI innovations expected to further advance Starlink. Raymond James is particularly optimistic, expecting the stock to reach $800 per share and viewing SpaceX as a foundational company for the 21st century's industrial capacity.
SpaceX founder Elon Musk decided to take the company public to secure funding for its ambitious goals, including establishing a Mars colony and launching data centers into space. However, the Starship rocket is still in its test phase, and technologies for space data centers or Mars colonization do not yet exist. Analysts acknowledge that delays or failures with Starship launches pose a significant risk to their forecasts. SpaceX debuted on Wall Street with a market value exceeding $2 trillion, a level it largely maintains, though Musk's net worth has fluctuated below $1 trillion. MoffettNathanson, a more cautious firm, has a neutral rating and a $131 price target, citing unknowns related to regulation, technology, and demand.